[Congressional Record Volume 168, Number 158 (Thursday, September 29, 2022)]
[Senate]
[Pages S5660-S5661]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 6103. Ms. MURKOWSKI (for herself, Mrs. Feinstein, Mr. Sullivan, 
and Ms. Hassan) submitted an amendment intended to be proposed to 
amendment SA 5499 submitted by Mr. Reed (for himself and Mr. Inhofe) 
and intended to be proposed to the bill H.R. 7900, to authorize 
appropriations for fiscal year 2023 for military activities of the 
Department of Defense, for military construction, and for defense 
activities of the Department of Energy, to prescribe military personnel 
strengths for such fiscal year, and for other purposes; which was 
ordered to lie on the table; as follows:

        At the appropriate place, insert the following:

     SEC. ___. PROGRAMS TO ADDRESS SUBSTANCE USE DISORDER.

       (a) Short Title.--This section may be cited as ``Bruce's 
     Law''.
       (b) Awareness Campaigns.--
       (1) Opioid program.--Section 102 of the Comprehensive 
     Addiction and Recovery Act of 2016 (Public Law 114-198) is 
     amended--
       (A) in the section heading, by inserting ``relating to 
     opioids'' after ``campaigns''; and
       (B) in subsection (c)--
       (i) in paragraph (1), by inserting ``and'' after the 
     semicolon;
       (ii) in paragraph (2)(B), by striking ``; and'' and 
     inserting a period; and
       (iii) by striking paragraph (3).
       (2) Additional campaign.--Title I of the Comprehensive 
     Addiction and Recovery Act of 2016 (Public Law 114-198) is 
     amended by inserting after section 102 the following:

     ``SEC. 102A. AWARENESS CAMPAIGN RELATED TO LETHALITY OF 
                   FENTANYL AND FENTANYL-CONTAMINATED DRUGS.

       ``(a) In General.--The Secretary of Health and Human 
     Services, in coordination with the heads of other Federal 
     departments and agencies, shall, as appropriate, through a 
     public awareness campaign, advance the education and 
     awareness of the public (including school-aged children, 
     youth, parents, first responders, and providers) and other 
     appropriate entities regarding the risk of counterfeit drugs 
     being contaminated with fentanyl or other synthetic opioids 
     and the lethality and other dangers of synthetic opioids.
       ``(b) Topics.--The education and awareness campaigns under 
     subsection (a) shall address--
       ``(1) the dangers of using drugs which may be contaminated 
     with fentanyl or other synthetic opioids;
       ``(2) the prevention of substance use disorder and use of 
     drugs other than as prescribed, including through safe 
     disposal of prescription medications and other safety 
     precautions; and
       ``(3) the detection of early warning signs of substance use 
     disorder and addiction in school-aged children and youth.
       ``(c) Other Requirements.--The education and awareness 
     campaigns under subsection (a) shall, as appropriate, take 
     into account any association between the use of prescription 
     drugs other than as prescribed and the use of drugs that can 
     be contaminated by fentanyl or other synthetic opioids, 
     including heroin.
       ``(d) Drug Defined.--In this section, the term `drug' means 
     an illicit drug, such as marijuana, hashish, cocaine 
     (including crack cocaine), inhalants, hallucinogens, heroin, 
     a synthetic opioid, methamphetamine or other stimulant, a 
     counterfeit prescription drug, or a prescription drug that is 
     sold illegally.
       ``(e) Authorization of Appropriations.--There are 
     authorized to be appropriated for fiscal years 2023 through 
     2027 such sums as may be necessary to carry out this 
     section.''.
       (c) Federal Interagency Work Group on Fentanyl 
     Contamination of Illegal Drugs.--Title I of the Comprehensive 
     Addiction and Recovery Act of 2016 (Public Law 114-198), as 
     amended by subsection (b)(2), is further amended by inserting 
     after section 102A the following:

     ``SEC. 102B. FEDERAL INTERAGENCY WORK GROUP ON FENTANYL 
                   CONTAMINATION OF ILLEGAL DRUGS.

       ``(a) Establishment.--The Secretary of Health and Human 
     Services (referred to in this section as the `Secretary') 
     shall establish the Federal Interagency Work Group on 
     Fentanyl Contamination of Illegal Drugs (referred to in this 
     section as the `Work Group').
       ``(b) Membership; Consultation.--
       ``(1) Composition.--Not later than 120 days after the date 
     of enactment of Bruce's Law, the heads of the Office of 
     National Drug Control Policy, the Substance Abuse and Mental 
     Health Services Administration, the Administration for 
     Children and Families, the Centers for Disease Control and 
     Prevention, the Department of Justice, the Drug Enforcement 
     Administration, the Department of State, the Department of 
     Education, and other Federal agencies (as determined by the 
     Secretary) shall designate representatives of the respective 
     agency or office to the Work Group.
       ``(2) Consultation.--The Work Group shall consult with--
       ``(A) experts at the State, Tribal, and local levels with 
     relevant backgrounds in reducing, preventing, and responding 
     to drug overdose by fentanyl contamination of illegal drugs;
       ``(B) individuals in recovery from misuse of fentanyl or 
     other synthetic opioids;
       ``(C) family members of adults who have overdosed by 
     fentanyl-contaminated illegal drugs;
       ``(D) family members of school-aged children and youth who 
     have overdosed by fentanyl-contaminated illegal drugs;
       ``(E) researchers and other experts in the design and 
     implementation of effective drug-related messaging and 
     prevention campaigns; and
       ``(F) technology companies.
       ``(c) Duties.--The Work Group shall--
       ``(1) examine all Federal efforts directed towards reducing 
     and preventing drug overdose by fentanyl- or other synthetic 
     opioid-contaminated illegal drugs;
       ``(2) identify strategies, resources, and supports to 
     improve State, Tribal, and local responses to overdose by 
     fentanyl- or other synthetic opioid-contaminated illegal 
     drugs;
       ``(3) make recommendations to Congress for improving 
     Federal programs and efforts and coordination across such 
     programs and efforts to reduce and prevent drug overdose by 
     fentanyl- or other synthetic opioid-contaminated illegal 
     drugs; and
       ``(4) make recommendations for educating youth on the 
     dangers of drugs contaminated by fentanyl or other synthetic 
     opioids.
       ``(d) Annual Report to Secretary.--The Work Group shall 
     annually prepare and submit to the Secretary, the Committee 
     on Health, Education, Labor, and Pensions of the Senate, and 
     the Committee on Education and Labor and the Committee on 
     Energy and Commerce of the House of Representatives, a report 
     on the activities carried out by the Work Group under 
     subsection (c), including recommendations to reduce and 
     prevent drug overdose by fentanyl or other synthetic opioid 
     contamination of illegal drugs, in all populations, and 
     specifically among youth at risk for substance use disorder 
     and use of drugs other than as prescribed.''.
       (d) Community-based Coalition Enhancement Grants to Address 
     Local Drug Crises.--Section 103(i) of the Comprehensive 
     Addiction and Recovery Act of 2016 (21 U.S.C. 1536(i)) is 
     amended by striking ``2017 through 2021'' and inserting 
     ``2023 through 2027''.
       (e) Community-based Coalition Enhancement Grants to Educate 
     Youth on the Risks of Drugs Contaminated With Fentanyl or 
     Other Synthetic Opioids.--Title I of the Comprehensive 
     Addiction and Recovery Act of 2016 (Public Law 114-198) is 
     amended by inserting after section 103 the following:

     ``SEC. 103A. COMMUNITY-BASED COALITION ENHANCEMENT GRANTS TO 
                   EDUCATE YOUTH ON THE RISKS OF DRUGS 
                   CONTAMINATED WITH FENTANYL OR OTHER SYNTHETIC 
                   OPIOIDS.

       ``(a) Program Authorized.--The Director of the Office of 
     National Drug Control Policy (referred to in this section as 
     the `Director'), in coordination with the Director of the 
     Centers for Disease Control and Prevention, may make grants 
     to eligible entities to implement education of the public on 
     the dangers of contamination of drugs with fentanyl or other 
     synthetic opioids.
       ``(b) Application.--
       ``(1) In general.--An eligible entity seeking a grant under 
     this section shall submit an application to the Director at 
     such time, in such manner, and accompanied by such 
     information as the Director may require.
       ``(2) Criteria.--As part of an application for a grant 
     under this section, the Director shall require an eligible 
     entity to submit a detailed, comprehensive, multisector plan 
     for addressing the implementation of an evidence-based public 
     education campaign on the dangers of drugs contaminated with 
     fentanyl or other synthetic opioids, with a specific 
     consideration given to education focused on youth at 
     increased risk for developing a substance use disorder.
       ``(3) Eligible entities.--For purposes of this section, the 
     term `eligible entity'--
       ``(A) means an entity that has documented, using local 
     data, rates of drug overdose related to fentanyl or other 
     synthetic opioids at levels that are significant, as 
     determined by the Director; and
       ``(B) may include an entity that has received a grant under 
     the Drug-Free Communities Act of 1997.
       ``(c) Use of Funds.--An eligible entity shall use a grant 
     received under this section--
       ``(1) for programs designed to implement comprehensive 
     community-wide prevention strategies to address the dangers 
     of drugs contaminated with fentanyl or other synthetic 
     opioids, in the area served by the eligible entity, in 
     accordance with the plan submitted under subsection (b)(2);

[[Page S5661]]

       ``(2) to obtain specialized training and technical 
     assistance from the organization funded under section 4 of 
     Public Law 107-82 (21 U.S.C. 1521 note); and
       ``(3) for programs designed to implement comprehensive 
     community-wide strategies to address the dangers of drugs 
     contaminated with fentanyl or other synthetic opioids in the 
     community.
       ``(d) Supplement Not Supplant.--An eligible entity shall 
     use Federal funds received under this section only to 
     supplement the funds that would, in the absence of those 
     Federal funds, be made available from other Federal and non-
     Federal sources for the activities described in this section, 
     and not to supplant those funds.
       ``(e) Evaluation.--A grant under this section shall be 
     subject to the same evaluation requirements and procedures as 
     the evaluation requirements and procedures imposed on the 
     recipient of a grant under the Drug-Free Communities Act of 
     1997, and shall also include an evaluation of the 
     effectiveness at reducing the use of illicit fentanyl or 
     other synthetic opioids.
       ``(f) Limitation on Administrative Expenses.--Not more than 
     12 percent of the amounts made available to carry out this 
     section for a fiscal year may be used to pay for 
     administrative expenses.
       ``(g) Delegation Authority.--The Director may enter into an 
     interagency agreement with the Director of the Centers for 
     Disease Control and Prevention to delegate authority for the 
     execution of grants and for such other activities, as the 
     Director determines necessary to carry out this section.
       ``(h) Definition.--In this section, the term `drug' means 
     an illicit drug, such as marijuana, hashish, cocaine 
     (including crack cocaine), inhalants, hallucinogens, heroin, 
     a synthetic opioid, methamphetamine or other stimulant, a 
     counterfeit prescription drug, or a prescription drug that is 
     sold illegally.
       ``(i) Authorization of Appropriations.--For the purpose of 
     carrying out this section, there are authorized to be 
     appropriated such sums as may be necessary for each of fiscal 
     years 2023 through 2027.''.
                                 ______